Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|April 27, 2011
Hypofrontality in schizophrenic patients and its relevance for the choice of antipsychotic medication: an event-related potential studyAnn-Christine Ehlis, Paul Pauli, Martin J Herrmann, et al.
The International Journal of Neuropsychopharmacology|June 14, 2013
Quetiapine and flupentixol differentially improve anterior cingulate cortex function in schizophrenia patients: an event-related potential studySabrina Schneider, Thomas Juergen Bahmer, Florian Gerhard Metzger, et al.
Nordic Journal of Psychiatry|February 21, 2013
Serious suicidal behaviors: socio-demographic and clinical features in a multinational, multicenter sampleVladimir Carli, Laura Mandelli, Leonardo Zaninotto, et al.
Schizophrenia Research|November 10, 2022
Parakinesia: A Delphi consensus reportJack R Foucher, Andreas J Bartsch, Olivier Mainberger, et al.
Dialogues in Clinical Neuroscience|July 24, 2020
Wernicke-Kleist-Leonhard phenotypes 
of endogenous psychoses: a review of their validity
Jack R Foucher, Micha Gawlik, Julian N Roth, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 23, 2021
The polysemous concepts of psychomotricity and catatonia: A European multi-consensus perspectiveJack R Foucher, Ludovic C Jeanjean, Clément C de Billy, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|March 2, 2018
TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians<sup/>Georgios Schoretsanitis, Michael Paulzen, Stefan Unterecker, et al.
Der Nervenarzt|November 18, 2018
[Therapeutic drug monitoring in neuropsychopharmacology : Summary of the consensus guidelines 2017 of the TDM task force of the AGNP]Stefan Unterecker, Gudrun Hefner, Pierre Baumann, et al.
Pharmacopsychiatry|July 2, 2026
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2026 - Pharmacokinetic, pharmacogenetic and clinical aspectsXenia M Hart, Gerhard Gründer, Christoph Hiemke, et al.
Nature|April 9, 2022
Mapping genomic loci implicates genes and synaptic biology in schizophreniaVassily Trubetskoy, Antonio F Pardiñas, Ting Qi, et al.
Pageof 4